These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

753 related articles for article (PubMed ID: 33157161)

  • 21. Role of protein glycosylation in cancer metastasis.
    Oliveira-Ferrer L; Legler K; Milde-Langosch K
    Semin Cancer Biol; 2017 Jun; 44():141-152. PubMed ID: 28315783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Divergent Enzymatic Assembly of a Comprehensive 64-Membered IgG N-Glycan Library for Functional Glycomics.
    Ma W; Xu Z; Jiang Y; Liu J; Xu D; Huang W; Li T
    Adv Sci (Weinh); 2023 Oct; 10(30):e2303832. PubMed ID: 37632720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific glycosylation of membrane proteins in epithelial ovarian cancer cell lines: glycan structures reflect gene expression and DNA methylation status.
    Anugraham M; Jacob F; Nixdorf S; Everest-Dass AV; Heinzelmann-Schwarz V; Packer NH
    Mol Cell Proteomics; 2014 Sep; 13(9):2213-32. PubMed ID: 24855066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isomer-specific profiling of N-glycans derived from human serum for potential biomarker discovery in pancreatic cancer.
    Liu Y; Wang C; Wang R; Wu Y; Zhang L; Liu BF; Cheng L; Liu X
    J Proteomics; 2018 Jun; 181():160-169. PubMed ID: 29674015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immature truncated O-glycophenotype of cancer directly induces oncogenic features.
    Radhakrishnan P; Dabelsteen S; Madsen FB; Francavilla C; Kopp KL; Steentoft C; Vakhrushev SY; Olsen JV; Hansen L; Bennett EP; Woetmann A; Yin G; Chen L; Song H; Bak M; Hlady RA; Peters SL; Opavsky R; Thode C; Qvortrup K; Schjoldager KT; Clausen H; Hollingsworth MA; Wandall HH
    Proc Natl Acad Sci U S A; 2014 Sep; 111(39):E4066-75. PubMed ID: 25118277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycosylation in the Era of Cancer-Targeted Therapy: Where Are We Heading?
    Mereiter S; Balmaña M; Campos D; Gomes J; Reis CA
    Cancer Cell; 2019 Jul; 36(1):6-16. PubMed ID: 31287993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Repertoire of Glycan Alterations and Glycoproteins in Human Cancers.
    Kori M; Aydin B; Gulfidan G; Beklen H; Kelesoglu N; Caliskan Iscan A; Turanli B; Erzik C; Karademir B; Arga KY
    OMICS; 2021 Mar; 25(3):139-168. PubMed ID: 33404348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How glycosylation affects glycosylation: the role of N-glycans in glycosyltransferase activity.
    Mikolajczyk K; Kaczmarek R; Czerwinski M
    Glycobiology; 2020 Dec; 30(12):941-969. PubMed ID: 32363402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycosylation and cancer: moving glycomics to the forefront.
    Drake RR
    Adv Cancer Res; 2015; 126():1-10. PubMed ID: 25727144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered expression of glycan genes in cancers induced by epigenetic silencing and tumor hypoxia: clues in the ongoing search for new tumor markers.
    Kannagi R; Sakuma K; Miyazaki K; Lim KT; Yusa A; Yin J; Izawa M
    Cancer Sci; 2010 Mar; 101(3):586-93. PubMed ID: 20085584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alteration of N-glycans and expression of their related glycogenes in the epithelial-mesenchymal transition of HCV29 bladder epithelial cells.
    Guo J; Li X; Tan Z; Lu W; Yang G; Guan F
    Molecules; 2014 Dec; 19(12):20073-90. PubMed ID: 25470275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MALDI Mass Spectrometry Imaging of N-Linked Glycans in Cancer Tissues.
    Drake RR; Powers TW; Jones EE; Bruner E; Mehta AS; Angel PM
    Adv Cancer Res; 2017; 134():85-116. PubMed ID: 28110657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sweet systems: technologies for glycomic analysis and their integration into systems biology.
    Chen S; Qin R; Mahal LK
    Crit Rev Biochem Mol Biol; 2021 Jun; 56(3):301-320. PubMed ID: 33820453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer glycomics offers potential biomarkers and therapeutic targets in the framework of 3P medicine.
    Guo Y; Jia W; Yang J; Zhan X
    Front Endocrinol (Lausanne); 2022; 13():970489. PubMed ID: 36072925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CRISPR/Cas9 and glycomics tools for
    Gas-Pascual E; Ichikawa HT; Sheikh MO; Serji MI; Deng B; Mandalasi M; Bandini G; Samuelson J; Wells L; West CM
    J Biol Chem; 2019 Jan; 294(4):1104-1125. PubMed ID: 30463938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integration of Web-Based Tools to Visualize, Integrate, and Interpret Glycogene Expression and Glycomics Data.
    Subramanian SP; Gundry RL
    Methods Mol Biol; 2024; 2836():97-109. PubMed ID: 38995538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. When Glycosylation Meets Blood Cells: A Glance of the Aberrant Glycosylation in Hematological Malignancies.
    Su H; Wang M; Pang X; Guan F; Li X; Cheng Y
    Rev Physiol Biochem Pharmacol; 2021; 180():85-117. PubMed ID: 34031738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Sugars Interfere or Glycomics in the Field of Cancer Biomarkers].
    Zahradníková M; Vojtěšek B; Hernychova L
    Klin Onkol; 2015; 28 Suppl 2():2S20-5. PubMed ID: 26374154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycobiology of cellular expiry: Decrypting the role of glycan-lectin regulatory complex and therapeutic strategies focusing on cancer.
    Kumar Das A; Ghosh N; Mandal A; Sil PC
    Biochem Pharmacol; 2023 Jan; 207():115367. PubMed ID: 36481348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identifying N-Glycan Biomarkers in Colorectal Cancer by Mass Spectrometry.
    Sethi MK; Hancock WS; Fanayan S
    Acc Chem Res; 2016 Oct; 49(10):2099-2106. PubMed ID: 27653471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.